Remifentanil Hydrochloride Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-723

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Remifentanil Hydrochloride (NDC 63323-723). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Rem02 0002 01)

Chemical structure diagram of Remifentanil Hydrochloride, depicting its molecular framework with key functional groups and bonds.*

FDA Label Image

Figure 1 (Rem02 0002 02)

A line graph comparing minute ventilation (% of baseline) over time (minutes) for Remifentanil Hydrochloride and Alfentanil during and after infusion. The x-axis represents time before, during, and post-infusion, while the y-axis shows minute ventilation as a percentage of baseline. Data points with error bars are plotted for both drugs across the timeline.*

FDA Label Image

Figure 2 (Rem02 0002 03)

A line graph depicting mean (sd) concentration (ng/mL) of two drugs, Alfentanil and Remifentanil HCl, over time in minutes. The graph compares concentration levels from 0 to 480 minutes for Alfentanil at 0.5 mcg/kg/min and Remifentanil HCl at 0.05 mcg/kg/min, showing different pharmacokinetic profiles with error bars indicating variability.*

FDA Label Image

Rem02 0002 04

FDA Label Image

Rem02 0002 05

Label for Remifentanil Hydrochloride Injection, Powder, Lyophilized, for Solution with strength of 1 mg per vial. The label indicates the product is for intravenous use only and must be reconstituted and diluted before use. It is labeled by Fresenius Kabi USA, LLC, Lake Zurich, IL. The label includes NDC barcode and space for lot and expiration date.*

FDA Label Image

Rem02 0002 06

Label for Remifentanil Hydrochloride for Injection 1 mg per vial, a lyophilized powder for intravenous injection, manufactured by Fresenius Kabi USA, LLC. The label indicates the product contains 1 mg of remifentanil per vial and is available in a package of 10 single-dose vials. Instructions for reconstitution and storage (2° to 25°C) are included, along with the National Drug Code (NDC 63323-723). The label also notes that the product is for intravenous use only and prescription use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.